🇺🇸 Habitrol in United States

FDA authorised Habitrol on 27 November 1991

Marketing authorisations

FDA — authorised 27 November 1991

  • Application: NDA020076
  • Marketing authorisation holder: DR REDDYS LABS SA
  • Local brand name: HABITROL
  • Indication: FILM, EXTENDED RELEASE — TRANSDERMAL
  • Status: approved

Read official source →

FDA — authorised 29 December 2008

  • Application: ANDA078697
  • Marketing authorisation holder: P AND L
  • Status: supplemented

FDA — authorised 29 December 2008

  • Application: ANDA078699
  • Marketing authorisation holder: P AND L
  • Status: supplemented

FDA — authorised 8 July 2009

  • Application: ANDA079044
  • Marketing authorisation holder: P AND L
  • Status: supplemented

FDA — authorised 8 July 2009

  • Application: ANDA079038
  • Marketing authorisation holder: P AND L
  • Status: supplemented

FDA

  • Status: approved

Other Other approved in United States

Frequently asked questions

Is Habitrol approved in United States?

Yes. FDA authorised it on 27 November 1991; FDA authorised it on 29 December 2008; FDA authorised it on 29 December 2008.

Who is the marketing authorisation holder for Habitrol in United States?

DR REDDYS LABS SA holds the US marketing authorisation.